Company / Free Cash Flow per Share
Maze Therapeutics, Inc. Free Cash Flow per Share History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$46.07
FY2025
5-year range
-$46.07 / -$46.07
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#190 of 192
Health Care
What the data says
Among 192 Health Care companies, Maze Therapeutics, Inc. is in the bottom 1% for free cash flow per share.
Based on SEC 10-K filings.
-46.07 in FY2025.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 192This company -$46.07 Sector average -$19.84
▼
-132.2% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$46.07 | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026